tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Altimmune Inc (ALT)
NASDAQ:ALT
US Market
ALT
Altimmune
RESEARCH TOOLSreports

Altimmune (ALT) Stock News & Sentiment

Compare
3,536 Followers
Altimmune, Pure Storage, Globalstar, Cipher Mining, AutoZone Shake-Up
Premium
Weekend Updates
Altimmune, Pure Storage, Globalstar, Cipher Mining, AutoZone Shake-Up
3d ago
ALT
AZO
Altimmune’s IMPACT NASH Trial Completion Puts Pemvidutide Back in the Spotlight
Premium
Company Announcements
Altimmune’s IMPACT NASH Trial Completion Puts Pemvidutide Back in the Spotlight
4d ago
ALT
Pemvidutide’s Strong Phase 2b Data and De-Risked Phase 3 Path in MASH Support Altimmune Buy Rating and $12 Target
Premium
Ratings
Pemvidutide’s Strong Phase 2b Data and De-Risked Phase 3 Path in MASH Support Altimmune Buy Rating and $12 Target
11d ago
ALT
Balanced Risk-Reward for Altimmune’s Pemvidutide in a Crowded MASH Landscape Supports Hold Rating
Premium
Ratings
Balanced Risk-Reward for Altimmune’s Pemvidutide in a Crowded MASH Landscape Supports Hold Rating
11d ago
ALT
Altimmune reports positive Phase 2b pemvidutide MASH results
Premium
Company Announcements
Altimmune reports positive Phase 2b pemvidutide MASH results
11d ago
8K
ALT
Altimmune Announces CEO Transition Plan
Premium
Company Announcements
Altimmune Announces CEO Transition Plan
29d ago
8K
ALT
Altimmune Reports Q3 2025 Financial and Business Progress
Premium
Company Announcements
Altimmune Reports Q3 2025 Financial and Business Progress
2M ago
ALT
More ALT News >

ALT News on the Web

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround
Zacks
Neutral
Altimmune, Pure Storage, Globalstar, Cipher Mining, AutoZone Shake-Up
TipRanks News
Neutral
ALT’s Pemvidutide Shows Significant Antifibrotic Benefits at 48 Weeks: Phase 2b Results Point Toward Phase 3 Trial
Market Chameleon
Neutral
ALT’s Pemvidutide Shows Significant Antifibrotic Benefits at 48 Weeks: Phase 2b Results Point Toward Phase 3 Trial
Market Chameleon
Neutral
Why Altimmune, Inc.’s (ALT) Stock Is Up 10.51%
AAII
Neutral
Altimmune Stock Falls 20% After Pemvidutide 48-Week Trial Update
rttnews
Bearish
Altimmune's Pemvidutide Achieves Key Fibrosis And Weight Loss Endpoints At 48 Weeks
rttnews
Neutral
ALT’s Pemvidutide Achieves Strong 48-Week Efficacy in MASH: Significant Reductions in Liver Fibrosis and Sustained Weight Loss Highlight Phase 2b Results
Market Chameleon
Neutral

News Score - Last 7 Days

Neutral
ALT
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALT’s Media Buzz Sentiment?
3 articles about ALT were published this week. In an average week, 3.25 articles are published.
    What is ALT’s weekly average amount of articles?
    In an average week, 3.25 articles about ALT are published.
      What is ALT’s News Sentiment?
      50% of articles about ALT were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        DVAXDynavax
        AGIOAgios Pharma
        BHVNBiohaven Ltd.
        EWTXEdgewise Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week